Ascendis Pharma A/S (ASND)
245.20
+1.83
(+0.75%)
USD |
NASDAQ |
Oct 26, 12:30
Ascendis Pharma Price : 245.20 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 242.00 | 244.58 | 240.79 | 243.37 | 575676.0 |
| Oct 22, 2026 | 239.38 | 243.87 | 236.87 | 242.99 | 539178.0 |
| Oct 21, 2026 | 236.00 | 240.21 | 235.50 | 238.90 | 662120.0 |
| Oct 20, 2026 | 230.19 | 235.88 | 229.88 | 234.33 | 394744.0 |
| Oct 19, 2026 | 227.44 | 233.19 | 225.81 | 229.95 | 1.268M |
| Oct 16, 2026 | 226.62 | 226.76 | 223.78 | 225.25 | 680329.0 |
| Oct 15, 2026 | 230.40 | 234.01 | 226.06 | 226.62 | 403968.0 |
| Oct 14, 2026 | 222.54 | 227.83 | 222.00 | 227.00 | 995684.0 |
| Oct 13, 2026 | 225.99 | 228.91 | 222.21 | 223.21 | 592246.0 |
| Oct 12, 2026 | 229.00 | 229.23 | 226.66 | 227.00 | 667448.0 |
| Oct 09, 2026 | 225.08 | 233.96 | 223.96 | 229.23 | 815743.0 |
| Oct 08, 2026 | 227.83 | 227.98 | 219.52 | 222.69 | 924773.0 |
| Oct 07, 2026 | 224.36 | 229.00 | 223.05 | 228.41 | 820548.0 |
| Oct 06, 2026 | 229.21 | 230.91 | 222.72 | 226.05 | 1.092M |
| Oct 05, 2026 | 229.66 | 230.73 | 226.84 | 228.03 | 783227.0 |
| Oct 02, 2026 | 227.63 | 229.02 | 225.20 | 227.87 | 641436.0 |
| Oct 01, 2026 | 228.03 | 229.88 | 226.00 | 227.31 | 805981.0 |
| Sep 30, 2026 | 227.97 | 230.97 | 226.18 | 227.83 | 926230.0 |
| Sep 29, 2026 | 227.42 | 229.89 | 223.70 | 228.07 | 741868.0 |
| Sep 28, 2026 | 226.00 | 231.14 | 224.80 | 230.05 | 747554.0 |
| Sep 25, 2026 | 230.13 | 230.43 | 224.26 | 225.60 | 419975.0 |
| Sep 24, 2026 | 223.00 | 231.13 | 220.23 | 230.70 | 1.166M |
| Sep 23, 2026 | 236.83 | 237.98 | 220.60 | 223.13 | 1.218M |
| Sep 22, 2026 | 239.09 | 240.69 | 234.67 | 237.57 | 548315.0 |
| Sep 21, 2026 | 238.66 | 241.50 | 237.00 | 237.59 | 822985.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioMarin Pharmaceutical, Inc. | 55.69 |
| Novo Nordisk A/S | 39.03 |
| Evaxion AS | 3.015 |
| Genmab A/S | 44.38 |
| Zealand Pharma A/S | 33.88 |
Price Related Metrics
| PE Ratio | 18.68 |
| PS Ratio | 12.80 |
| Price to Book Value | 9.805 |
| Price to Free Cash Flow | 40.20 |
| Earnings Yield | 5.35% |
| Market Cap | 16.10B |
| Operating PE Ratio | 124.10 |
| Normalized PE Ratio | 18.68 |